Small gains, real risks
What might PT-141 findings mean for you?
You can see how much women improved, what went wrong, and why their results can't answer every question about your health.
What matters most before you read further?
A medicine for desire, PT-141 acts within your brain. Here you'll find who was helped, what went wrong, and the approval limits. In 2019, the FDA granted bremelanotide approval to treat distressing lost desire in women before menopause, which means their periods haven't ended permanently [3][7]. For that approved use, the medicine is given in a shot just below the skin.
PT-141 hasn't been approved for men, erection trouble, better sexual performance, or women after menopause [1][7]. Your doctor may call those uses “off-label,” meaning outside the approval. Some uses are still being tested, so you can't assume they work. I'd want that settled before weighing a hopeful claim about myself.
PT-141 affects desire; erection pills improve the blood supply your penis needs [1]. Those are different problems, even if you face both at once. Powders offered for lab work don't have the approved medicine's quality checks. You can read about unwanted experiences on the effects page.
Why does PT-141 work differently from an erection pill?
The seven parts in lab-made PT-141 are amino acids, which also make up proteins [1]. Joined in a ring, these parts copy a natural brain hormone. Your body uses hormones to send messages from one part to another.
PT-141 prompts cells in the brain that influence both desire and hunger [1]. These cells work within brain areas that help control those urges [1]. For your erections, a pill works by improving blood flow instead. Bremelanotide is another name you'll hear for the medicine [3].
What did women actually say had improved?
Women wanted sex a little more, and their lack of desire bothered them less. Two Phase 3 trials, large studies before approval, included 1,267 women before menopause and tested 1.75 mg shots, taken when needed and delivered just below the skin, rather than daily treatment. Over 24 weeks, answers about desire improved by 0.35 points more than with a placebo, a shot without the tested medicine [3].
Question 13 concerned how often the women felt bothered about wanting sex so little. Their answers showed 0.33 points less distress than with the placebo. Each difference is well under a point on the study questions, without proof of a big daily change. You can't tell from those averages how much any one woman felt helped.
A 52-week follow-up of 684 women found that improved desire continued [4]. Researchers didn't find new safety problems, but sickness, flushing, and headaches remained common. Continued benefit doesn't mean the women felt much better every day. Those findings don't promise you the same response.
A brain scan study included 31 women upset about wanting sex so little. More desire was reported for up to 24 hours, compared with placebo [5]. As women looked at sexual images, scans showed changed links between brain areas. You can learn how the medicine acts without learning whether it will help you.
Which women does the approval include?
Approval is for women still before menopause, distressed because they want sex so little [7]. Their desire used to be normal, so the problem isn't lifelong. Desire stays low across situations, rather than only with a certain partner. Approval doesn't cover a man seeking better erections or performance [7].
Here's the limit that matters for your choices. Larger amounts produced stronger erections when men were tested early on [1]. In 2024, a Phase 2 study, an early trial, began testing the drug alongside an erection medicine [14]. Starting a study doesn't prove a benefit or give men an approved treatment.
What happens when you see a doctor by phone or video?
A review explains checks doctors make on sexual health when a visit uses the phone or video [8]. The doctor weighs your health and whether care can reach you this way. Research also followed the growth of these visits during COVID-19 [13]. You still need a health check before a prescribing decision.
You can compare the findings discussed in PT-141 reviews. Our PT-141 benefits page explains the gains and what remains uncertain. PT-141 research and PT-141 references let you look more closely at the studies. These pages can't provide you with clinic care or fill a prescription.
Where can you look up unwanted experiences?
The PT-141 reports and cautions page explains unwanted effects people describe. You'll find both sickness and concerns about lasting changes. Those accounts can't tell you your own chance of harm.